WO2005092330A1 - Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe - Google Patents
Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe Download PDFInfo
- Publication number
- WO2005092330A1 WO2005092330A1 PCT/EP2005/003199 EP2005003199W WO2005092330A1 WO 2005092330 A1 WO2005092330 A1 WO 2005092330A1 EP 2005003199 W EP2005003199 W EP 2005003199W WO 2005092330 A1 WO2005092330 A1 WO 2005092330A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- vitamin
- medicament
- agent according
- blueberry extract
- minim
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4415—Pyridoxine, i.e. Vitamin B6
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/525—Isoalloxazines, e.g. riboflavins, vitamin B2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/08—Oxides; Hydroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/45—Ericaceae or Vacciniaceae (Heath or Blueberry family), e.g. blueberry, cranberry or bilberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Definitions
- the invention relates to a medicament or dietetic for oral administration, which contains blueberry extract, as well as antioxidants and micronutrients selected from magnesium oxide, pangamic acid (vitamin B15), vitamin B1, vitamin B2, selenium, vitamin B6, vitamin B12 and L-ascorbic acid.
- blueberry extract as well as antioxidants and micronutrients selected from magnesium oxide, pangamic acid (vitamin B15), vitamin B1, vitamin B2, selenium, vitamin B6, vitamin B12 and L-ascorbic acid.
- blueberries as fresh fruit or (dry) extract
- circulatory disorders such as varices, hemorrhoids, diarrhea and a number of eye diseases such as cataracts, diabetogenic retinopathy, glaucoma, macular degeneration and night blindness as well as overuse of the eyes ( Computer) is widely used.
- the present invention accordingly provides a new, highly effective, purely natural medicament or dietetic which is suitable for the prophylaxis and treatment of headaches, in particular for tension headaches and migraines.
- the drugs according to the invention are natural, purely herbal formulations, which also of Patients who are opposed to allopathy are well accepted and tolerated.
- Blueberry extract according to the invention means a dry extract of the berries of Vaccinium myrtillus, i.e. the European blueberry, which is also called “Büberry” in Anglo-Saxon usage.
- a particularly preferred dry extract in the sense of the invention is standardized to at least 25% anthocyanosides.
- a typical extract used according to the invention contains up to 4.5% water, up to 5% mineral components (Sulfuric ashes), up to 5% free anthocyanidins and
- Extract is commercially available e.g. as "Bilberry Purified Dry Extract”.
- Dry extract can be made in a manner known per se from liquid drug extracts, e.g. through percolation, maceration, Soxiet method, digestion especially after
- Fresh blueberries are pressed to obtain a blueberry juice concentrate, which is then subjected to ultrafiltration and ethanol extraction or aqueous-alcoholic extraction.
- the extract obtained is concentrated in vacuo to a paste and dried to a powder, which is then ground to give the blueberry dry extract.
- a preferred formulation according to the invention contains per dosage unit, such as tablet or capsule:
- the dietetics or pharmaceuticals according to the invention can also pharmaceutical formulation auxiliaries such as fillers (carriers), such as Soybean oil or partially hydrogenated soybean oil for soft gelatin capsules, disintegrants, binders, flow regulators, lubricants, emulsifiers, solvents or sorbents.
- carriers such as Soybean oil or partially hydrogenated soybean oil for soft gelatin capsules
- disintegrants such as Soybean oil or partially hydrogenated soybean oil for soft gelatin capsules
- binders such as binders, flow regulators, lubricants, emulsifiers, solvents or sorbents.
- the dietetics or medicaments according to the invention can be formulated in any dosage form which is suitable for oral administration by methods customary in the art, solid dosage forms for oral administration such as tablets, hard gelatin capsules and soft gelatin capsules being preferred.
- Soft gelatin capsules are very particularly preferred. According to the invention, preference is given here to oval soft capsules of sizes 2 to 20 minim and oblong soft capsules of sizes 6 to 22 minim, in particular oval soft capsules of size 10 minim.
- the dosage form in special primary packaging such as blister packs or blister packs, i.e. is blistered.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Alternative & Traditional Medicine (AREA)
- Botany (AREA)
- Mycology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE202004004618U DE202004004618U1 (de) | 2004-03-24 | 2004-03-24 | Blaubeerextrakt |
DE202004004618.0 | 2004-03-24 | ||
DE202004006157U DE202004006157U1 (de) | 2004-03-24 | 2004-04-19 | Arzneimittel bzw. Nahrungsergänzungsmittel |
DE202004006157.0 | 2004-04-19 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2005092330A1 true WO2005092330A1 (de) | 2005-10-06 |
Family
ID=34964615
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2005/003199 WO2005092330A1 (de) | 2004-03-24 | 2005-03-24 | Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2005092330A1 (de) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006011922A1 (de) * | 2006-03-15 | 2007-09-20 | Uwe Stoldt | Mittel zur Behandlung von Tinnitus |
WO2009146711A2 (en) * | 2008-06-03 | 2009-12-10 | Aarhus Universitet | Method for purification of natural cobalamins by adsorption on insoluble materials containing carboxylic groups |
CN110771710A (zh) * | 2019-10-11 | 2020-02-11 | 浙江欧谱生物科技有限公司 | 一种增加骨量、抑制骨丢失的保健食品组合物及其应用 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19529955C1 (de) * | 1995-02-13 | 1996-04-18 | Dariush Behnam | Tafelwasser, Heilwasser oder dergleichen nicht alkoholisches Getränk |
WO1999066943A1 (en) * | 1998-06-25 | 1999-12-29 | Curt Hendrix | Dietary supplement for supporting cerebrovascular tone |
DE20012510U1 (de) * | 2000-07-17 | 2000-11-30 | Klingmueller Martin | Multivitamin- und Mineralstoffpräparat |
EP1057483A1 (de) * | 1998-02-23 | 2000-12-06 | Taiyo Kagaku Co., Ltd. | Theanin-beinhaltende zusammenstellung |
RU2197256C2 (ru) * | 2000-09-25 | 2003-01-27 | Иркутская государственная сельскохозяйственная академия | Лекарственное растительное средство "секрет молодости" для омоложения человеческого организма |
US20030108630A1 (en) * | 2001-11-02 | 2003-06-12 | Stephen Story | Morinda citrifolia enhanced naturaceutical formulation and method for treating and preventing migraine headaches |
US6649195B1 (en) * | 2002-07-11 | 2003-11-18 | Vitacost.Com, Inc. | Eyesight enhanced maintenance composition |
-
2005
- 2005-03-24 WO PCT/EP2005/003199 patent/WO2005092330A1/de active Application Filing
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19529955C1 (de) * | 1995-02-13 | 1996-04-18 | Dariush Behnam | Tafelwasser, Heilwasser oder dergleichen nicht alkoholisches Getränk |
EP1057483A1 (de) * | 1998-02-23 | 2000-12-06 | Taiyo Kagaku Co., Ltd. | Theanin-beinhaltende zusammenstellung |
WO1999066943A1 (en) * | 1998-06-25 | 1999-12-29 | Curt Hendrix | Dietary supplement for supporting cerebrovascular tone |
DE20012510U1 (de) * | 2000-07-17 | 2000-11-30 | Klingmueller Martin | Multivitamin- und Mineralstoffpräparat |
RU2197256C2 (ru) * | 2000-09-25 | 2003-01-27 | Иркутская государственная сельскохозяйственная академия | Лекарственное растительное средство "секрет молодости" для омоложения человеческого организма |
US20030108630A1 (en) * | 2001-11-02 | 2003-06-12 | Stephen Story | Morinda citrifolia enhanced naturaceutical formulation and method for treating and preventing migraine headaches |
US6649195B1 (en) * | 2002-07-11 | 2003-11-18 | Vitacost.Com, Inc. | Eyesight enhanced maintenance composition |
Non-Patent Citations (2)
Title |
---|
DATABASE WPI Section Ch Week 200338, Derwent World Patents Index; Class B04, AN 2003-400671, XP002339057 * |
HEYCK H: "[Pangamic acid in migraine]", DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT. 18 APR 1969, vol. 94, no. 16, 18 April 1969 (1969-04-18), pages 867, XP009051407, ISSN: 0012-0472 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102006011922A1 (de) * | 2006-03-15 | 2007-09-20 | Uwe Stoldt | Mittel zur Behandlung von Tinnitus |
WO2007104566A1 (de) * | 2006-03-15 | 2007-09-20 | Uwe Stoldt | Mittel zur behandlung von tinnitus |
EA013457B1 (ru) * | 2006-03-15 | 2010-04-30 | Уве Штольдт | Средство для лечения шума в ушах |
WO2009146711A2 (en) * | 2008-06-03 | 2009-12-10 | Aarhus Universitet | Method for purification of natural cobalamins by adsorption on insoluble materials containing carboxylic groups |
WO2009146711A3 (en) * | 2008-06-03 | 2010-04-22 | Aarhus Universitet | Method for purification of natural cobalamins by adsorption on insoluble materials containing carboxylic groups |
CN110771710A (zh) * | 2019-10-11 | 2020-02-11 | 浙江欧谱生物科技有限公司 | 一种增加骨量、抑制骨丢失的保健食品组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8790687B2 (en) | Triterpene compounds which are effective on improvement of brain function | |
US20190290713A1 (en) | Medical Compositions and Kits Including Those Compositions II | |
EP3116520A1 (de) | Phytokomplexe aus citrus bergamia | |
US6248307B1 (en) | Compositions and treatment for alleviation of symptoms associated with menopause | |
WO2000074696A1 (en) | Combination of glucosamine with herbal extracts of tripterygium, ligustrum and erycibe | |
EP1609466B1 (de) | Pharmazeutische Zusammensetzung, Verwendung dieser pharmazeutischen Zusammensetzung zur Herstellung eines Medikaments und/oder eines Nahrungsergänzungmittels zur Behandlung von Übergewicht und/oder Symptomen, die mit Übergewicht einhergehen, beim Menschen oder Säugetier, sowie Verfahren zur Herstellung dieser pharmazeutischen Zusammensetzung | |
WO2005092330A1 (de) | Arzneimittel oder diätetikum zur oralen verabreichung enthaltend blaubeerextrakt sowie antioxidatien und mikronährstoffe | |
EP2106705B1 (de) | Verwendung einer Zusammensetzung, welche ein Pflanzenlektin, ein proteolytisches Enzym und eine Selenverbindung umfasst, zum Schleimhautschutz und zur Linderung anderer Symptome bei Krebspatienten | |
US9566309B2 (en) | Compositions for treatment of cancer-related fatigue | |
DE102006011922A1 (de) | Mittel zur Behandlung von Tinnitus | |
WO2010072209A2 (de) | Nahrungsergänzungsmittel auf der basis von pantothensäure | |
EP1886690B1 (de) | Pharmazeutische Zusammensetzung zur Anwendung bei Nahrungsmittelunverträglichkeiten | |
US6923967B1 (en) | Treatment of dyspepsia | |
DE202004006157U1 (de) | Arzneimittel bzw. Nahrungsergänzungsmittel | |
DE202007008818U1 (de) | Zusammensetzung zur Behandlung von Infekten | |
EP2688577B1 (de) | Zusammensetzung zur anwendung bei verdauungsbeschwerden | |
US7867524B2 (en) | Energizing formulation | |
KR100204166B1 (ko) | 항스트레스 조성물 | |
WO2021240293A1 (en) | Combination of active ingredients, compositions containing it and their use to sustain and strengthen the immune system | |
KR20010046562A (ko) | 골 관절염 치료를 위한 건강식품 조성물 | |
DE202006012340U1 (de) | Pharmazeutische Zusammensetzung, insbesondere zur Anwendung bei Nahrungsmittelunverträglichkeiten | |
AT16167U1 (de) | Kombinationspräparat zur diätetischen behandlung von darmbeschwerden bei reizdarmsyndrom | |
Bozorgi | 12 Drimia maritima (L.) Stearn | |
EP1638576A1 (de) | Kombination von acetylsalicyls ure und alpha-glucosidase-inh ibitoren | |
KR20010019396A (ko) | 혈액순환 장애 개선용 조성물 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: DE |
|
122 | Ep: pct application non-entry in european phase | ||
WWE | Wipo information: entry into national phase |
Ref document number: 11722322 Country of ref document: US |